|   |   | 
Legal status
Patent expired
| (51) | INT.CL. | A61K 38/28 | (2006.01) | 
| A61P 3/10 | (2006.01) | 
| (11) | Number of the document | 2918286 | 
| (13) | Kind of document | T | 
| (96) | European patent application number | 15161696.8 | 
| Date of filing the European patent application | 2005-10-05 | |
| (97) | Date of publication of the European application | 2015-09-16 | 
| (45) | Date of publication and mention of the grant of the patent | 2020-03-18 | 
| (46) | Date of publication of the claims translation | 2020-04-10 | 
| (30) | Number | Date | Country code | 
| 200401519 | 2004-10-05 | DK | 
| (72) | 
                    
                    
                    
                    
                    Berglund, Petter, DK  
                    
                    
                    
                    
                    Hammelev, Charlotte, DK  
                    
                    
                    
                    
                    Eskildsen, Lone, DK  
                    
                    
                    
                    
                    Madsen, Johanne, DK  
                    
                    
                    
                    
                    Olsen, Helle Aalund, DK  
                    
                    
                    
                    
                    Kimer, Lone Logstrup, DK  | 
| (73) | Novo Nordisk A/S,
                Corporate Patents  Novo Allé, 2880 Bagsvęrd,
                DK | 
| (74) | Reda ŽABOLIENĖ,
                METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
                LT | 
| (54) | Farmacinis preparatas, kurio sudėtyje yra kristalinės ir taip pat ištirpintos formos insulino | 
| PHARMACEUTICAL PREPARATION CONTAINING INSULIN IN CRYSTALLINE AS WELL AS IN SOLUBILIZED FORM | 
| Payment date | Validity (years) | Amount | |
| 2024-09-19 | 347.00 EUR |